Current Oncology, Free Full-Text

Triple-negative breast cancer (TNBC) has a worse prognosis and remains the most challenging breast cancer subtype to treat. This is largely related to the heterogeneity of this disease and the lack of reliable oncological targets. In this review, we discuss the current standard-of-care treatment options for metastatic TNBC, including recent advances with the use of immunotherapy, PARP inhibitors and antibody-drug conjugates. This review also explores new agents and novel combinations arising in the field for the treatment of advanced TNBC.

402+ Free Editable Oncology Templates in MS Word [DOC] - Page 22

Current Oncology, Free Full-Text

Current Oncology, Free Full-Text

Current Oncology 2023 - Browse Issues

Journal of Clinical Oncology

New Cardio-Oncology Resources Page on - American College

Creative Options, ADT Program, Creative Options

7th Singapore Society of Oncology Annual Scientific Meeting 2022 – Malaysian Oncological Society

Oncology News Today

CancerCare Coping with Stomach Cancer During the Holidays

A Multicentre, Randomised Trial Comparing Schedules Of, 44% OFF

The interRAI CHESS scale is comparable to the palliative performance scale in predicting 90-day mortality in a palliative home care population, BMC Palliative Care, chess rating test

Current Oncology, Free Full-Text